HDAC as a Therapeutic Target for Treatment of Endometrial Cancers

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|11|1847-1856

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1847-1856

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hsp27 as a Therapeutic Target in Cancers

By  

Current Drug Targets, Vol. 15, Iss. 4, 2014-04 ,pp. : 423-431

Bentham Science Publishers

Access to resources Recommend Favorite

HDAC Inhibitors-New Generation of Target Specific Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-11 ,pp. : 1263-1276

Bentham Science Publishers

Access to resources Recommend Favorite

Potential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages

By Ceccarelli Simona   Romano Ferdinando   Angeloni Antonio   Marchese Cinzia  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 377-393

Informa Healthcare

Access to resources Recommend Favorite

HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers

By Manzo-Merino Joaquin   Thomas Miranda   Fuentes-Gonzalez Alma M   Lizano Marcela   Banks Lawrence  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1357-1368

Informa Healthcare

Access to resources Recommend Favorite

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

By  

Current Medicinal Chemistry, Vol. 24, Iss. 32, 2017-10 ,pp. : 3485-3507

Bentham Science Publishers

Access to resources Recommend Favorite